Target intelligence / Profile preview

LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated pseudogene 2 (LSM6P2)

Target
LSM6P2
Molecular classification
Other
01

Overview

LSM6P2 refers to a pseudogene named "LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated pseudogene 2." According to genomic databases, it is not a protein-coding gene but a pseudogene related to the functional LSM6 gene found in yeast (S. cerevisiae)[7][9]. Pseudogenes are genomic DNA sequences similar to normal genes but are typically non-functional due to mutations or lack of regulatory elements required for expression. Thus, LSM6P2 does not produce a functional protein and is not considered a therapeutic target or biologically active molecule. Key clarifications: - LSM6P2 is not an active gene, receptor, or enzyme — it is a pseudogene. - There is no evidence it has any biological, therapeutic, or molecular “target” role[7][9]. - It is not implicated in disease, drug action, biomarker use, or safety concerns. If you require structured information for the functional family (e.g., “LSM6 homologs”), focus on the protein-coding LSM6 or related Sm-like proteins; LSM6P2 itself is not a target and is listed as a pseudogene by key databases[7][9].

Other names
LSM6P2LSM6 homolog pseudogene 2

Beyond the preview

Go deeper on LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated pseudogene 2 (LSM6P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated pseudogene 2 (LSM6P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call